International Clinical Trial: Study on how TREM1 and ODF2L regulate macrophages in COPD with lung cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132676) titled 'Study on how TREM1 and ODF2L regulate macrophages in COPD with lung cancer' on Sept. 17.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Zhejiang Provincial Hospital of TCM

Condition: chronic obstructive pulmonary disease (COPD) and lung cancer

Intervention: Lung cancer tumor tissue group:None healthy lung tissue control:None COPD patient lung tissue group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Lung cancer tumor tissue group:10;healthy lung tissue control:10;COPD patient lung tissue group:10;COPD control ...